+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis



Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis



International Journal of Oncology 44(1): 211-221



We performed whole exome sequencing and gene expression analysis on a metastatic colon cancer to the lung, along with the adjacent normal tissue of the lung. Whole exome sequencing uncovered 71 high-confidence non‑synonymous mutations. We selected 16 mutation candidates, and 13 out of 16 mutations were validated by targeted deep sequencing using the Ion Torrent PGM customized AmpliSeq panel. By integrating mutation, copy number and gene expression microarray data, we identified a JAZF1 mutation with a gain-of-copy, suggesting its oncogenic potential for the lung metastasis from colon cancer. Our pathway analyses showed that the identified mutations closely reflected characteristics of the metastatic site (lung) while mRNA gene expression patterns kept genetic information of its primary tumor (colon). The most significant gene expression network was the 'Colorectal Cancer Metastasis Signaling', containing 6 (ADCY2, ADCY9, APC, GNB5, K-ras and LRP6) out of the 71 mutated genes. Some of these mutated genes (ADCY9, ADCY2, GNB5, K-ras, HDAC6 and ARHGEF17) also belong to the 'Phospholipase C Signaling' network, which suggests that this pathway and its mutated genes may contribute to a lung metastasis from colon cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052270583

Download citation: RISBibTeXText

PMID: 24172857

DOI: 10.3892/ijo.2013.2150


Related references

Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling. Plos one 8(5): E63597, 2013

Whole Exome Sequencing to Map the Genomic Evolution of Metastatic Prostate Cancer. Human Mutation 34(9): Iv-Iv, 2013

Exome sequencing reveals comprehensive genomic alterations across eight cancer cell lines. Plos one 6(6): E21097, 2011

Immune response-associated gene analysis of 1,000 cancer patients using whole-exome sequencing and gene expression profiling-Project HOPE. Biomedical Research 37(4): 233-242, 2016

Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis. Annals of Oncology 28(9): 2135-2141, 2017

Bi-29 * Variant Analysis Of Primary And Recurrent Glioblastoma Using Ion Ampliseqtm Comprehensive Cancer Panel And Whole Exome Sequencing. Neuro-Oncology 16(Suppl 5): v29-v30, 2014

Exome sequencing and case-control analyses identify RCC1 as a candidate breast cancer susceptibility gene. International Journal of Cancer 142(12): 2512-2517, 2018

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nature Genetics 44(10): 1111-1116, 2012

Genomic ERBB2 / ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis. Gut 68(6): 1024-1033, 2019

Identification of a rare germline NBN gene mutation by whole exome sequencing in a lung-cancer survivor from a large family with various types of cancer. Familial Cancer 16(3): 389-394, 2017

Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis. Cancer 113(2): 266-275, 2008

Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer. Oncotarget 9(27): 19223-19232, 2018

Use of low-melting-point primers for bisulfite genomic sequencing: analysis of the H37 lung cancer tumor suppressor gene promoter. Analytical Biochemistry 343(2): 347-349, 2005

Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients. Plos one 11(8): E0161012, 2016

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer. Clinical Cancer Research 25(15): 4691-4700, 2019